United Kingdom

People: Cerecor Inc (CERC.OQ)

CERC.OQ on NASDAQ Stock Exchange Capital Market

9:00pm BST
Change (% chg)

$-0.10 (-2.80%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Calias, Pericles 

Dr. Pericles Calias is Chief Scientific Officer of the Company. From May 2017 to May 2018, Dr. Calias was the vice president global CMC and product development at Sucampo Pharmaceuticals, Inc., a global biopharmaceutical company. Since June 2014, Dr. Calias has led Educational Trainers and Consultants, an independent consultancy group that provides support throughout all stages of pharmaceutical and device development, in advising multiple companies on their drug development. Prior to that, from 2007 to 2014, he served in various positions at Shire HGT, a leading global biotechnology company focused on serving people with rare diseases. He holds a Ph.D. in Organic Chemistry from Tufts University and a B.S. in biology from Suffolk University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --